Quarterly Result13 Nov 2025, 07:02 pm
Kilitch Drugs India Ltd Announces Q2 Results with 40% YoY Revenue Growth
AI Summary
Kilitch Drugs India Ltd has announced its Q2 results for the year ended 30th September, 2025. The company reported a standalone revenue of INR 378,135 Lakhs, representing a 40% YoY growth. The net profit for the quarter stood at INR 871.57 Lakhs, a 102.83% YoY increase. The company's total income for the quarter was INR 454,224 Lakhs, up by 18.16% from the same period last year.
Key Highlights
- Q2 revenue stands at INR 378,135 Lakhs, a 40% YoY growth
- Net profit for the quarter is INR 871.57 Lakhs, a 102.83% YoY increase
- Total income for the quarter is INR 454,224 Lakhs, up by 18.16% YoY
- Recent rights issue of equity shares for funding the capital expenditure for Greenfield Project at Pen
- Predominantly engaged in the business of Pharmaceuticals